Indaptus Therapeutics files to sell 1.94M shares of common stock [Seeking Alpha]
Indaptus Therapeutics, Inc. Announces $2.135 Million Registered Direct Offering and Concurrent Private Placement [Yahoo! Finance]
Indaptus Therapeutics, Inc. Announces $2.135 Million Registered Direct Offering and Concurrent Private Placement
Indaptus Therapeutics, Inc. (NASDAQ: INDP) had its price target lowered by analysts at Maxim Group from $8.00 to $5.00. They now have a "buy" rating on the stock.
Indaptus Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update